First Bank & Trust Viatris Inc Transaction History

First Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$9.95 - $12.27 $149 - $184	-15 Reduced 33.33%	30 $0
Q4 2021 Feb 01, 2022	SELL	$12.09 - $14.68 $858 - $1,042	-71 Reduced 61.21%	45 $1,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $2,594 - $3,229	-200 Reduced 63.29%	116 $2,000
Q1 2021 Apr 14, 2021	SELL	$13.59 - $18.54 $95,184 - $129,854	-7,004 Reduced 95.68%	316 $4,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $104,676 - $137,176	7,320 New	7,320 $137,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.